- Home
- NHC vs DYN Comparison
NHC vs DYN Comparison
Compare NHC & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NHC
- DYN
- Stock Information
- Founded
- NHC 1971
- DYN 1984
- Country
- NHC United States
- DYN United States
- Employees
- NHC N/A
- DYN N/A
- Industry
- NHC Hospital/Nursing Management
- DYN Medicinal Chemicals and Botanical Products
- Sector
- NHC Health Care
- DYN Health Care
- Exchange
- NHC Nasdaq
- DYN Nasdaq
- Market Cap
- NHC 1.8B
- DYN 1.9B
- IPO Year
- NHC N/A
- DYN 2020
- Fundamental
- Price
- NHC N/A
- DYN $14.51
- Analyst Decision
- NHC
- DYN Strong Buy
- Analyst Count
- NHC 0
- DYN 14
- Target Price
- NHC N/A
- DYN $34.93
- AVG Volume (30 Days)
- NHC 94.3K
- DYN 2.5M
- Earning Date
- NHC 11-07-2025
- DYN 11-11-2025
- Dividend Yield
- NHC 2.14%
- DYN N/A
- EPS Growth
- NHC 12.96
- DYN N/A
- EPS
- NHC 6.70
- DYN N/A
- Revenue
- NHC $1,458,155,000.00
- DYN N/A
- Revenue This Year
- NHC N/A
- DYN N/A
- Revenue Next Year
- NHC N/A
- DYN N/A
- P/E Ratio
- NHC $17.58
- DYN N/A
- Revenue Growth
- NHC 24.46
- DYN N/A
- 52 Week Low
- NHC $89.14
- DYN $6.36
- 52 Week High
- NHC $136.86
- DYN $35.90
- Technical
- Relative Strength Index (RSI)
- NHC N/A
- DYN 59.18
- Support Level
- NHC N/A
- DYN $12.43
- Resistance Level
- NHC N/A
- DYN $14.27
- Average True Range (ATR)
- NHC 0.00
- DYN 0.73
- MACD
- NHC 0.00
- DYN 0.04
- Stochastic Oscillator
- NHC 0.00
- DYN 85.53
About NHC National HealthCare Corporation
National Healthcare Corp Provides long-term care facilities. Its principal business includes the operation of skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services, and Home care hospice services. Generating, a majority of its revenue from Inpatient services.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.